Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer Stock Tumbles On 'A Big Setback' In Obesity Treatment Vs. Novo Nordisk, Eli Lilly

Pfizer stock toppled Monday after the company tossed out a potential diabetes and weight-loss drug that leads to elevated liver enzymes.

Investors Business Daily

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24.

The Hindu

What Covid has in store for winter

Pharmaceutical giant Pfizer say forewarned is forearmed when it comes to potentially spiking Covid numbers in the winter months

Newsroom.co.nz

From analysis to the latest developments in health,
read the most diverse news in one place.

Two million Brits have been taking antidepressants for five years or more

Brits' long-term dependence on anti-depressants has been laid bare as figures show a quarter of people using the drugs have been taking them for more than five years

Daily Mirror

Warren Entsch denies he helped LNP donor get Pfizer vaccine during supply crisis

Allegation raised in parliament that MP arranged for property developer Alex Sekler to travel to Torres Strait for Covid jab referred to state corruption watchdog

The Guardian - AU

MP denies quid pro quo over COVID-19 jab for donor

The federal health minister has accused Liberal MP Warren Enstch of allowing a wealthy donor to use a COVID-19 vaccine dose intended for Indigenous people.

AAP

COVID boosters should be updated to target XBB strain, US health advisers say

COVID-19 shots should be reformulated to target an XBB subvariant of the highly infectious omicron strain to provide the best protection during the U.S. fall and winter season, health regulators said.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Pfizer warns of a looming penicillin supply shortage

The shortage comes as there has been a steady increase in rates of syphilis since 2000. Inventory can start depleting as early as this month, Pfizer said.

WEKU

Pfizer Warns Of Potential Pediatric Antibiotic Shortage Amid Surge In Syphilis Infections

Pfizer Inc cautions about potential supply shortages for pediatric Bicillin L-A, an antibiotic for syphilis treatment.

Zenger

Lady Gaga raises eyebrows over paid partnership with Pfizer migraine drug

Singer is an ‘actual patient’ using the drug Nurtec ODT

The Independent UK

Should You Buy Into Pfizer (PFE) Today?

Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength of its in-line products and expected near-term launches and revenue distribution from the recent acquisition. So, let’s find out if…

StockNews.com

Kerala CM invites Pfizer to open research centre at Digital Sciences Park in Thiruvananthapuram

Chief Minister Pinarayi Vijayan lobbied with representatives of Pfizer, a global pharmaceutical major, to start a research wing in Kerala.

The Hindu

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Which Pharma Stock is a Pick for June: Pfizer (PFE) or SNDL Inc. (SNDL)?

The pharmaceutical industry is known for its resilience during challenging economic times, primarily due to the inelastic demand for essential medicines. As the specter of a potential recession hangs over the market, let us analyze two leading players in the sector, Pfizer (PFE) and SNDL (SNDL), to find the better…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

The anti-vaxxer threat keeps spreading

With vaccines on the horizon, RSV could finally be preventable. But anti-vax misinfo could get in the way

Salon

Next COVID vax might drop OG strain

Scientists debate the benefits of bivalent and monovalent shots

Investors Business Daily

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree

Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers. Here's where things stand.

Investors Business Daily

Pfizer's Approach To Hemophilia Is 'Certainty Differentiated' — Here's Why Shares Fell

Pfizer said Tuesday its experimental hemophilia treatment cut down on bleeding episodes in a pivotal study. But Pfizer stock dipped.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected

An analyst expects Lilly to launch a competitor in weight-loss drugs a year earlier than expected, giving Eli Lilly stock a chance to shine.

The Independent UK

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid

StockNews.com

Buy, Sell, or Hold: Pfizer Inc. (PFE)

Pfizer (PFE) continues to make significant strides in the pharmaceutical industry, given its recent acquisition and drug approvals. Is the stock a buy, sell, or hold now? Keep reading to find out….

Investors Business Daily

The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes

Pfizer hasn't committed to sending a diabetes drug into Phase 3 testing. Instead, the company is waiting on results for another drug,

Investors Business Daily

S&P 500: Tesla Among Stock Winners Monday; Nike, Micron Slide

Match Group and Pfizer led mostly beaten down S&P 500 stocks rebounding Monday, but Tesla also rallied. Nike and Micron were key losers.

Investors Business Daily

Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss

An oral drug from Pfizer led to faster weight loss than weekly injections of Novo Nordisk's diabetes drug Ozempic. Pfizer stock jumped.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

1 … 21 22 23 24

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.